Evidence map›Paper›PMID 12719552›Full record

ArticleJournal of virology2003

Sindbis virus vectors designed to express a foreign protein as a cleavable component of the viral structural polyprotein.

John M Thomas, William B Klimstra, Kate D Ryman, Hans W Heidner

Open access · bronzeAbstract readEvaluation Study
In one paragraph

Article in Journal of virology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Article
  3. The advent of clinical self-amplifying RNA vaccines.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

John M ThomasDepartment of Biology, The University of Texas at San Antonio, San Antonio, Texas 78249, USA.
William B Klimstra
Kate D Ryman
Hans W Heidner
Louisiana State University Health Sciences Center Shreveport · USThe University of Texas at San Antonio · US

Funding

UTSA MBRS SCORE PROGRAMS06GM008194 · NIGMS · UNIVERSITY OF TEXAS SAN ANTONIO · PI TSIN, ANDREW T C · 1989 to 2006
$17.4M
MOLECULAR BASIS OF ALPHAVIRUS NEUROVIRULENCER01AI022186 · NIAID · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI KLIMSTRA, WILLIAM B · 1986 to 2004
$1.6M
ALPHAVIRUS REPLICATION IN CELLS OF THE ARTHROPOD VECTORR29AI040937 · NIAID · UNIVERSITY OF TEXAS SAN ANTONIO · PI HEIDNER, HANS W · 1998 to 2002
$257k
NIAID NIH HHS R01 AI022186NIAID NIH HHS R01 AI22186NIAID NIH HHS R29 AI40937NIGMS NIH HHS S06 GM008194NIGMS NIH HHS S06 GM08194
6 · The paper itself

Abstract

Alphavirus-based expression vectors commonly use a duplicated 26S promoter to drive expression of a foreign gene. Here we describe an expression strategy in which the foreign sequences are linked to the gene encoding the 2A protease of foot-and-mouth disease virus and then inserted in frame between the capsid and E3 genes of Sindbis virus. During replication, the 2A fusion protein is synthesized as a component of the viral structural polyprotein that is then released by intramolecular cleavages mediated by the capsid and 2A proteases. Recombinant Sindbis viruses that expressed fusion proteins composed of 2A linked to the green fluorescent protein (GFP) and to the VP7 protein of bluetongue virus were constructed. Viruses engineered to express GFP and VP7 from a duplicate 26S promoter were also constructed. All four viruses expressed the transgene and grew to similar titers in cultured cells. However, the GFP/2A- and VP7/2A-expressing viruses displayed greater expression stability and were less attenuated in newborn mice than the cognate double-subgenomic promoter-based viruses. By combining the two expression strategies, we constructed bivalent viruses that incorporated and expressed both transgenes. The bivalent viruses grew to lower titers in cultured cells and were essentially avirulent in newborn mice. Groups of mice were vaccinated with each VP7- and VP7/2A-expressing virus, and antibody responses to native VP7 were measured in an indirect enzyme-linked immunosorbent assay. Despite their genetic and phenotypic differences, all viruses induced similarly high titers of VP7-specific antibodies. These results demonstrate that 2A fusion protein-expressing alphaviruses may be particularly well suited for applications that require enduring expression of a single protein or coexpression of two alternative proteins.

Indexed as

Genetic VectorsAnimalsAnimals, NewbornAntibodies, ViralCell LineCricetinaeGreen Fluorescent ProteinsLuminescent ProteinsMicePolyproteinsRecombinant Fusion ProteinsSindbis VirusViral Core ProteinsViral ProteinsViral Structural ProteinsVirulenceAntibodies, ViralGreen Fluorescent ProteinsLuminescent ProteinsPolyproteinsRecombinant Fusion ProteinsViral Core ProteinsViral ProteinsViral Structural Proteinsvirus protein 2AVP7 protein, orbivirus

Identifiers

PMID12719552
PMCPMC154044
OpenAlexW2050645140

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.